MedPharm Launches Scientific Advisory Committee

MedPharm Ltd, a contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory Committee, headed by company founder and Board member, professor Marc Brown. Brown has served as MedPharm’s chief scientific officer for over 20 years and will be stepping down from his CSO role to chair the newly formed committee.

Comprised of international experts, the Scientific Advisory Committee will ensure that MedPharm continues to provide its clients with leading scientific services and access to beneficial strategic alliances. In addition to his role as committee chair, Brown will continue to provide technical as well as client support when required and remains a Board director.

Dr. Jon Lenn will take over the role of CSO, with responsibility for MedPharm’s global scientific operations. Lenn is well established as an authority in the development and optimization of topical products and has played a critical role in MedPharm's growth as well as the development and success of the Durham, NC site. More recently as chief technology officer, Lenn has guided the Innovation Team in the development of cutting-edge biological models and performance testing tools and supported client’s needs.  

“I would like to thank Marc for what he has accomplished as MedPharm’s scientific leader, and I am pleased that despite wanting to move away from day-to-day operations he has elected to remain engaged with MedPharm’s platform in a manageable fashion. With his support as chair of the Scientific Advisory Committee, we will continue our pioneering standard and remain the world leader in the topical and transdermal CDMO field,” commented Eugene Ciolfi, president & CEO. “Jon is the perfect individual to step into the CSO role. His unparalleled experience across both MedPharm and the Pharma industry will ensure our continued excellence in the science undertaken at MedPharm.”

These changes demonstrate MedPharm’s commitment to a global vision to expand services and remain at the forefront of the CDMO topical and transdermal product development industry.